Evaluation of immunization status in patients with cerebral palsy: A multicenter CP-VACC study
Erişim
info:eu-repo/semantics/closedAccessTarih
2022Yazar
Bozkaya Yılmaz, SemaKaradağ Öncel, Eda
Olgaç Dündar, Nihal
Gençpınar, Pınar
Sarıoğlu, Berrak
Arıcan, Pınar
Ersen, Atilla
Yılmaz Çiftdoğan, Dilek
Yüksel, Merve Feyza
Bektaş, Ömer
Teber, Serap
Kılıç, Betül
Çalık, Mustafa
Karaca, Meryem
Canpolat, Mehmet
Kumandaş, Sefer
Per, Hüseyin
Gümüş, Hakan
Öztürk, Selcan
Okuyaz, Çetin
Kömür, Mustafa
İpek, Rojan
Özbudak, Pınar
Arhan, Ebru
İnce, Hülya
Gürbüz, Gürkan
Mert, Gülen Gül
Özcan, Neslihan
Ölmez Türker, Akgün
Gazeteci Tekin, Hande
Kırık, Serkan
Günbey, Ceren
Çarman, Kürşat Bora
Yarar, Coşkun
Çavuşoğlu, Dilek
Üst veri
Tüm öğe kaydını gösterKünye
Bozkaya Yılmaz, S., Karadağ Öncel, E., Olgaç Dündar, N., Gençpınar, P., Sarıoğlu, B., Arıcan, P. ... Çavuşoğlu, D. (2022). Evaluation of immunization status in patients with cerebral palsy: A multicenter CP-VACC study. European Journal of Pediatrics, 181(1), 383-391. https://doi.org/10.1007/s00431-021-04219-4Özet
Children with chronic neurological diseases, including cerebral palsy (CP), are especially susceptible to vaccine-preventable infections and face an increased risk of severe respiratory infections and decompensation of their disease. This study aims to examine age-appropriate immunization status and related factors in the CP population of our country. This cross-sectional prospective multicentered survey study included 18 pediatric neurology clinics around Turkey, wherein outpatient children with CP were included in the study. Data on patient and CP characteristics, concomitant disorders, vaccination status included in the National Immunization Program (NIP), administration, and influenza vaccine recommendation were collected at a single visit. A total of 1194 patients were enrolled. Regarding immunization records, the most frequently administrated and schedule completed vaccines were BCG (90.8%), hepatitis B (88.9%), and oral poliovirus vaccine (88.5%). MMR was administered to 77.3%, and DTaP-IPV-HiB was administered to 60.5% of patients. For the pneumococcal vaccines, 54.1% of children received PCV in the scope of the NIP, and 15.2% of children were not fully vaccinated for their age. The influenza vaccine was administered only to 3.4% of the patients at any time and was never recommended to 1122 parents (93.9%). In the patients with severe (grades 4 and 5) motor dysfunction, the frequency of incomplete/none vaccination of hepatitis B, BCG, DTaP-IPV-HiB, OPV, and MMR was statistically more common than mild to moderate (grades 1-3) motor dysfunction (p = 0.003, p < 0.001, p < 0.001, p < 0.00, and p < 0.001, respectively). Physicians' influenza vaccine recommendation was higher in the severe motor dysfunction group, and the difference was statistically significant (p = 0.029).
Conclusion: Children with CP had lower immunization rates and incomplete immunization programs. Clinicians must ensure children with CP receive the same preventative health measures as healthy children, including vaccines.
WoS Q Kategorisi
Q1Scopus Q Kategorisi
Q1Kaynak
European Journal of PediatricsCilt
181Sayı
1Koleksiyonlar
- Makale Koleksiyonu [3650]
- PubMed İndeksli Yayınlar Koleksiyonu [4047]
- Scopus İndeksli Yayınlar Koleksiyonu [6283]
- WoS İndeksli Yayınlar Koleksiyonu [6432]